Intracranial hypertension after MECT: successful transition to rTMS for refractory auditory hallucinations: a case report - Report - MDSpire

Intracranial hypertension after MECT: successful transition to rTMS for refractory auditory hallucinations: a case report

  • By

  • Liang Lv

  • Meng-Yun Guan

  • July 13, 2026

Share

Management of Intracranial Hypertension Following MECT: A Case Study

Background

Schizophrenia is characterized by persistent auditory hallucinations, affecting 60%-80% of patients. Treatment-resistant auditory hallucinations pose significant challenges, as first-line antipsychotic medications often fail. MECT can lead to adverse effects such as intracranial hypertension.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • A 21-year-old female with schizophrenia developed intracranial hypertension after MECT.
  • She experienced severe symptoms including headache, vomiting, and diplopia.
  • Following rTMS treatment, her auditory hallucinations diminished significantly within 3 days.
  • Her symptoms resolved completely within one week, with improved social functioning.
  • No recurrence of symptoms was observed during a 3-week follow-up.

Clinical Implications

Monitoring for elevated intracranial pressure following MECT is important, especially in patients with a history of migraine.

Conclusion

This case suggests the need for further investigation into rTMS for managing refractory auditory hallucinations in patients with a history of intracranial hypertension post-MECT.

Related Resources & Content

  1. Frontiers in Psychiatry, 2026 -- Factors associated with treatment-emergent headache occurrence following RTMS to non-motor areas and the impact on treatment outcomes
  2. Frontiers in Psychiatry, 2026 -- Retrospective evaluation of transcranial magnetic stimulation for enhancing arousal in patients with minimally conscious state
  3. JAMA Network Open, 2023 -- Intermittent Theta-Burst Stimulation for Depression—Delineating Specific and Nonspecific Effects
  4. Electroconvulsive Therapy - StatPearls, NCBI Bookshelf
  5. Clinical Practice Guidelines for the Use of Electroconvulsive Therapy, PMC
  6. Frontiers in Neurology — The safety of Ipsilateral high-frequency repetitive Transcranial Magnetic Stimulation in brain tumour patients
  7. Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH), 2025
  8. Electroconvulsive Therapy - StatPearls - NCBI Bookshelf
  9. Clinical Practice Guidelines for the Use of Electroconvulsive Therapy - PMC
  10. Theta burst stimulation of temporo-parietal cortex regions for the treatment of persistent auditory hallucinations: a multicentre, randomised, sham-controlled, triple-blind phase 3 trial in Germany - ScienceDirect
  11. Efficacy of non-invasive brain stimulation in treatment-resistant schizophrenia: A systematic review and network meta-analysis - ScienceDirect
  12. Frontiers | Efficacy and safety of rTMS for global symptom severity, negative symptoms, and auditory hallucinations in treatment-resistant schizophrenia: A systematic review and meta-analysis
  13. https://dpsnet.dk/wp-content/uploads/2025/09/Danish-Psychiatric-Society-TMS-Guidelines-2025.pdf

Original Source(s)

Related Content